Clinical trial · people

Thymosin Alpha-1 combo: 47.8% viral response at 24 weeks in hep C

Checked against the paper Clinical trialPublished by PepVault

The takeaway

An early, uncontrolled pilot hints that thymalfasin in a triple combination may help some hepatitis C patients who failed prior therapy, but its own share of the effect remains untested.

Kind
Clinical trial
Studied in
People
Number studied
23
Published
2004
Journal
J Gastroenterol Hepatol

What they tested

The team tested whether a three-drug combination of thymalfasin, peginterferon alfa-2a and ribavirin could control the virus in people with chronic hepatitis C whose earlier interferon and ribavirin treatment had failed.

How the study was done

A small multicenter pilot trial in which 23 patients with chronic hepatitis C who had not cleared the virus on prior interferon and ribavirin all received the triple combination, with interim results at 24 weeks. There was no comparison group.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking Thymosin Alpha-1? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

A viral response was seen in 60.8% of patients at week 12 and in 47.8% at week 24. The researchers saw these early results as reason to keep studying the combination.

What it doesn’t show

With only 23 patients and no control arm, the trial can't show how much thymalfasin added beyond peginterferon and ribavirin. These are interim 24-week results from a pilot study, so they don't show whether the response lasted after treatment.

The paper

Poo et al. Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24-week interim results of a pilot study. J Gastroenterol Hepatol. 2004.

The compound

More studies on Thymosin Alpha-1

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking Thymosin Alpha-1? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo